Delivery Order SPE2DR25D1205-SPE2DR26F0ZU3
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $9,201.03 to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets in quantities of 100 units. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded and scheduled for completion by November 4, 2025. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets (100-count units) with a ceiling value of $1,229.86. The award, issued on December 18, 2025, with an ultimate completion date of December 19, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical federal...
- The Defense Logistics Agency awarded a delivery order valued at $2,065.08 to AmerisourceBergen Drug Corp for the supply of Glimepiride 1 mg tablets in quantities of 100 units. This firm fixed-price contract was competitively awarded without set-aside provisions and is scheduled for completion by December 19, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major...
- The Defense Logistics Agency awarded a $2,237.20 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets in quantities of 100 units. This contract, awarded on September 5, 2025, with an ultimate completion date of September 8, 2025, represents a small-value pharmaceutical procurement executed under a competitive, non-set-aside process. The delivery will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $2,771.49 to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets (100-count packaging) under a firm fixed-price contract. The award, issued on December 5, 2025, with completion targeted for December 8, 2025, will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting open competition among qualified...
- The Defense Logistics Agency awarded a delivery order valued at $2,950.40 to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets (100-count units) on January 9, 2026, with an ultimate completion date of January 12, 2026. This competitive, non-set-aside award reflects a firm fixed-price contract type and represents a routine pharmaceutical procurement from the vendor's place of performance in Conshohocken, Pennsylvania. The contract is executed as a child delivery order under...
- The Defense Logistics Agency awarded a delivery order valued at $5,217.54 to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets (100-count units) with an ultimate completion date of June 2, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement...
- The Defense Logistics Agency awarded a delivery order to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) on January 7, 2026, for the supply of Glimepiride 4 mg tablets in quantities of 100 units. This competitively awarded, firm fixed-price delivery order has a ceiling value of $3,130.05 and an ultimate completion date of January 8, 2026. The contract carries no set-aside designation. Amerisourcebergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $2,456.56 to AmerisourceBergen Drug Corp on January 13, 2026, for the supply of Glimepiride 4 mg tablets in quantities of 100 units. This is a firm fixed-price delivery order with no set-aside designation, meaning the contract was awarded through full and open competition. The awardee will perform this contract from its corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of January 14, 2026....
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets in quantities of 100 units under a firm fixed-price contract valued at $1,411.27. The order, issued on January 5, 2026, with an ultimate completion date of January 6, 2026, represents a non-competitive delivery order executed under an existing contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken,...
- SPE2DR25D1205Indefinite Delivery Contract
- SPE2DR25D1205-SPE2DR26F0ZU3Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $10,966.26 to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets in quantities of 100 units. This firm fixed-price delivery order, issued on January 12, 2026, will be completed by January 13, 2026, and represents a small but essential pharmaceutical procurement for federal medical supply needs. The contract carries no set-aside designation, indicating it was awarded through full and open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal healthcare systems, particularly those supporting military and veteran populations. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at up to $999,999,999.00 through December 31, 2031. This IDC enables the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains. The arrangement allows the Defense Logistics Agency to efficiently procure individual pharmaceutical products as needed to support defense healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.0k | 1/11/26 |